Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
Autolus Therapeutics, a Nasdaq-listed commercial-stage biopharmaceutical company specializing in next-generation T cell therapies, announced participation in two investor conferences in April 2026, including the Needham Virtual Healthcare Conference and the Van Lanschot Kempen Life Sciences Conference. The company will provide updates via webcast a…
TopBuild Corp. will announce its Q1 2026 financial results before market open on May 5, 2026, and host a conference call to discuss the results. The company is a leading installer and distributor of insulation and commercial roofing products in the U.S. and Canada.
Radiopharm Theranostics has signed an agreement with Siemens Healthineers to radiolabel and supply RAD101, its novel imaging agent for detecting brain metastases, in the U.S. The Phase 2b interim trial data showed significant tumor uptake with 90% concordance to MRI results. The partnership ensures supply for Radiopharm's upcoming Phase 3 registrat…
Plug Power Inc., a leading company in the hydrogen economy, announced its participation in a non-deal roadshow hosted by RBC in Toronto and Montreal. The meetings will allow institutional investors to discuss Plug Power's business strategy, operational execution, and path to profitability with company management. Plug Power aims to advance the hydr…
Baker Hughes has secured an order to provide three NovaLT16 gas turbines along with centrifugal compressors and services for a new natural gas pipeline project in Argentina. This will support gas transportation from Vaca Muerta to LNG vessels at the Gulf of San Matias. It marks the first use of Baker Hughes' NovaLT gas turbine technology in South A…
Highlander Silver Corp. announces the start of its first exploration drilling program in over a decade at the Corani Silver Project, alongside operational improvements at the Mercedes gold-silver mine and ongoing permitting and development activities. Following its merger with Bear Creek Mining, the company is positioned to fast-track project advan…
OKYO Pharma announced a Scientific Advisory Board meeting featuring leading ophthalmology experts in conjunction with the 2026 ASCRS Annual Meeting. The company will present positive Phase 2 clinical data on urcosimod, its investigational therapy for neuropathic corneal pain (NCP). Encouraged by the efficacy signals and safety profile, OKYO plans t…
Fury Gold Mines Limited has announced the appointment of Mario Courchesne as Vice President, Project Development. Courchesne brings over 40 years of mining engineering and project development experience, and will lead the advancement of the Eau Claire gold project from exploration to feasibility and potential production. The company also announced …
Liquidity Services announced that it will report its second quarter fiscal year 2026 financial results before market open on May 7, 2026, followed by a conference call hosted by its CEO and CFO. The company operates a leading global B2B e-commerce marketplace platform for surplus assets, facilitating sustainable asset lifecycle management and circu…
ANI Pharmaceuticals announced the publication of results from the NEW DAY clinical trial involving their ILUVIEN implant for diabetic macular edema (DME) in a leading ophthalmology journal. This publication reinforces the clinical evidence supporting ILUVIEN's use in appropriate DME patients, highlighting the company's commitment to advancing treat…
Fennec Pharmaceuticals announced that the University of Arizona Cancer Center is initiating an investigator-sponsored Phase I/II study evaluating the efficacy of PEDMARK® (sodium thiosulfate injection) in adolescent, young adult, and adult patients with solid tumors receiving cisplatin chemotherapy to prevent hearing loss. This study complements ot…
Invivyd, Inc. announced a national education campaign called Antibodies for Any Body in partnership with skier Lindsey Vonn to raise public awareness about antibodies and their role in immune health. The campaign features an interactive wellness assessment on AntibodiesforAnyBody.com designed to empower individuals to understand how lifestyle habit…
Uniti Solutions, a business unit of Uniti, has been awarded the Americas Service Provider of the Year at the 2026 Cato Networks Americas Partner Awards for the second year in a row. The recognition highlights their effective collaboration in delivering managed SASE services powered by Cato's SASE platform, improving secure networking for their cust…
Dole Food Company celebrates the 125th anniversary of its pineapple legacy with a series of events, product launches, and sustainability programs highlighting its commitment to environmental stewardship, social equity, and community support, including new initiatives at its pineapple farms and expanded product offerings.
WW International, Inc., the global leader in science-backed weight management, announced the appointment of Lisa Gavales and Sue Gove as independent directors to its Board. Both bring extensive experience in consumer brands, retail leadership, e-commerce, financial oversight, and public company governance. These strategic additions aim to support W…
NervGen Pharma announced the successful conclusion of the End-of-Phase 2 meeting with the FDA, securing alignment on the RESTORE Phase 3 registrational study evaluating NVG-291 for chronic tetraplegia. The FDA-endorsed study design includes a functional primary endpoint focused on hand use improvement, with initiation planned for mid-2026. Positive…
CervoMed Inc. announced new MRI analysis findings from its Phase 2b RewinD-LB clinical trial showing potential benefits of neflamapimod in reducing basal forebrain atrophy in DLB patients. The company also reported alignment with global regulatory authorities on its Phase 3 trial design and highlighted neflamapimod's potential as the first approved…
Palvella Therapeutics announced the appointment of Kent Taylor as Senior Vice President of Sales to spearhead the U.S. sales organization in preparation for the potential launch of QTORIN™ rapamycin, targeting rare, serious skin diseases and vascular malformations. Taylor brings over 25 years of pharmaceutical sales leadership, including successful…
Cognition Therapeutics, a clinical-stage biopharmaceutical company focused on neurodegenerative disorders, announced its CEO will present progress on its lead drug candidate, zervimesine (CT1812), at the 25th Annual Needham Virtual Healthcare Conference. Zervimesine, an oral treatment currently in Phase 2 trials, has shown promise for dementia with…
Plus Therapeutics announced that the American Medical Association has granted a new Proprietary Laboratory Analyses (PLA) code 0640U for its CNSide® CSF Tumor Cell Enumeration test, facilitating reimbursement and supporting the commercial launch in the U.S. This coding milestone is expected to enhance payer coverage, clinical adoption, and revenue …
Creative Realities, Inc., a Nasdaq-listed provider of digital signage, media and AdTech solutions, announced it will release its financial results for the quarter and full year ended December 31, 2025, on April 14, 2026, prior to market open. The company will host a conference call with management to discuss the results and business outlook. The an…
Univest Financial Corporation will release its first quarter 2026 earnings after market close on April 22, 2026, followed by a conference call for discussion on April 23, 2026. The company, based in Pennsylvania, is a regional financial institution offering banking, insurance, investment, and finance services primarily in the Mid-Atlantic region.
Akamai Technologies announced it will hold its first quarter 2026 earnings conference call on May 7, 2026, at 4:30 p.m. ET. The call will cover the company's financial results for Q1 2026 and may include forward-looking guidance from management. The event will be accessible via live dial-in and webcast, with a replay available for two weeks followi…
Artelo Biosciences, Inc., a clinical-stage pharmaceutical company, announced that it has regained compliance with Nasdaq listing requirements. The company highlighted progress in its clinical pipeline, including the ART27.13 candidate showing potential for cancer anorexia-cachexia syndrome and glaucoma, and ART26.12 for neuropathic pain. Management…
Wrap Technologies, Inc. announced that the Galveston Police Department has adopted its non-lethal response solutions by purchasing BolaWrap 150 devices and subscribing to WrapTactics training, supported by in-person training sessions. This move aims to enhance the department's capabilities in managing critical incidents with safer, non-lethal tools…
